Biogen sales face pressure from slow uptake of Alzhiemer's drug
Go back to Biogen sales face pressure from slow uptake of Alzhiemer's drug| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 197.82 -1.89 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $199.71 | 52 Week High | $333.65 | |||
| Open | $198.88 | 52 Week Low | $223.02 | |||
| Day High | $201.22 | P/E | 25.33 | |||
| Day Low | $197.74 | EPS | $7.81 | |||
| Volume | 453,023 | |||||
